<?xml version="1.0" encoding="UTF-8"?>
<ref id="B86" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Van der Stoep</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Quinten</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Alblas</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Plancke</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Van Eggermond</surname>
    <given-names class="given-names">M. C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Holling</surname>
    <given-names class="given-names">T. M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Van den Elsen</surname>
    <given-names class="given-names">P. J.</given-names>
   </name>
  </person-group> (
  <year class="year">2007</year>). 
  <article-title class="article-title">Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region</article-title>. 
  <source class="source">Mol. Immunol.</source>
  <volume class="volume">44</volume>, 
  <fpage class="fpage">2036</fpage>â€“
  <lpage class="lpage">2046</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.molimm.2006.09.013</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">17067677</pub-id>
 </mixed-citation>
</ref>
